Trials / Completed
CompletedNCT02867605
Human Pilot Study - HA35 (Hyaluronan Molecular Weight 35) Dietary Supplement for Promoting Intestinal Health
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- The Cleveland Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate whether oral HA35 supplementation changes the normal intestinal bacteria, increases intestinal protection, decrease intestinal inflammation and permeability, and to assess any health benefits and confirm the safety profile of HA35.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Hyaluronan |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2017-09-20
- Completion
- 2019-06-20
- First posted
- 2016-08-16
- Last updated
- 2020-09-03
- Results posted
- 2020-08-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02867605. Inclusion in this directory is not an endorsement.